Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information
The test substance was tested in a plate incorporation and pre-incubation assay in Salmonella typhimurium strains TA100, TA102, TA97a, TA 98 and TA 1535 in presence and absence of metabolic activation. No mutagenic effects were seen in both experiments. The number of revertant colonies was not increased in comparison with the spontaneous revertants. Therefore the test substance is considered not mutagenic under the test conditions.
Link to relevant study records
Reference
Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
10-02-2014 to 20-02-2014
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: study according to the guideline under GLP.
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay
Target gene:
Histidine
Species / strain / cell type:
S. typhimurium, other: LT2 TA 1535, TA 97a, TA 98, TA 100 and TA 102
Details on mammalian cell type (if applicable):
TA97a: hisD6610, uvrB, pKM 101, rfa
TA 98: hisD3052, uvrB, pKM 101, rfa
TA 100: hisG46, uvrB, pKM 101, rfa
TA102: hisG428, pKM 101, rfa
TA1535 : hisG46, uvrB, rfa.
Metabolic activation:
with and without
Metabolic activation system:
S9 produced from the livers of male Sprague-Dawley rats which were treated with 500 mg Aroclor 1254/kg body weight ip (Trinova Biochem. Gießen (Batch no. 3198)
Test concentrations with justification for top dose:
exp 1: 0.050, 0.150, 0.500 and 5.000 mg/plate.
exp 2 : 0.313, 0.625, 1.250, 2.500 and 5.000 mg/plate
Vehicle / solvent:
- Vehicle used: DMSO
- Justification for choice of solvent/vehicle: the test substance was sufficiently soluble. The background lawn was visible and the number of revertant colonies was not reduced.
Untreated negative controls:
yes
Remarks:
DMSO (positive control solvent)
Negative solvent / vehicle controls:
yes
Remarks:
DMSO
True negative controls:
yes
Remarks:
H2O
Positive controls:
yes
Remarks:
without metabolic activarion TA 97a, TA98 and TA102 : 4-Nitro-1,2-phenylene diamine; TA 1535 and TA 100 : Sodium azide ; with metabolic activation TA 97a, TA 100, TA 102 and TA 1535 : Aminoanthracene ; TA98: Benzo-a-pyrene
Positive control substance:
other: 4-Nitro-1,2-phenylene diamine; aminoanthracene
Details on test system and experimental conditions:
Cell cultures: Salmonella typhimurium (all strains used) were obtained from TRINOVA BioChem

METHOD OF APPLICATION: in medium; exp 1 preincubation; exp 2 in agar (plate incorporation)

DURATION
- Preincubation period (exp 1): 20 min
- Exposure duration: 48 h at 37 °C

SELECTION AGENT (mutation assays): histidine

CELL COUNT: visually

NUMBER OF REPLICATIONS: 4 per strain and concentration

NUMBER OF CELLS: titre determined to be 1.0E09 to 5.0E09 cells/mL
Evaluation criteria:
positive when: significant, reproducible increase of revertant colonies per plate (increase factor >2) in at least one strain. A concentration-related increase over the range tested can also be taken as a sign of mutagenic activity .
biological relevance is taken into account first
Statistics:
none performed
Species / strain:
S. typhimurium, other: LT2 TA 1535, TA 97a, TA 98, TA 100 and TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.
Conclusions:
Interpretation of results (migrated information):
negative

The test substance did not induce mutations in 5 strains of Salmonella typhimurium both in presence and absence of metabolic activation
Executive summary:

The test substance was tested in a plate incorporation and pre-incubation assay in Salmonella thypimurium strains TA100, TA102, TA97a, TA 98 and TA 1535 in presence and absence of metabolic activation. No mutagenic effects were seen in both experiments. The number of revertant colonies was not increased in comparison with the spontaneous revertants. Therefore the test substance is considered not mutagenic under the test conditions.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Additional information

Additional information from genetic toxicity in vitro:

Next to the Ames test with the substance, a chromosome aberration study and a mouse lymphoma assay are available with the salt of the structural analogue DNNSA. In view of the structural similarities between the substance and its analogue and the similar results in the Ames test (both negative with and without metabolic activation), it can be concluded that the substance is not expected to exhibit mutagenic or clastogenic effects.


Justification for selection of genetic toxicity endpoint
Guideline study under GLP

Justification for classification or non-classification

Based on the outcome of studies with the substance and the salt of its analogue, it is concluded that the substance is not mutagenic. No classification according to CLP (Regulation EC No 1272/2008) is considered necessary.